29 results
DEFA14A
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:08pm
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Social Post
SOCIAL POST
$IMGN Today we announced
10-K405
EX-10.37
imbv hm3zaoxe8
26 Sep 97
Annual report (delinquent filer disclosure)
12:00am
DEFA14A
EX-2.1
4b8prbnn2od2q am
30 Nov 23
Additional proxy soliciting materials
4:07pm
8-K
EX-2.1
gddl534cdg861b6xgon
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm